Influence of urapidil on in vitro platelet response to adrenaline and other aggregating agents
- 1 October 1988
- journal article
- research article
- Published by Elsevier in Pharmacological Research Communications
- Vol. 20 (10) , 883-899
- https://doi.org/10.1016/0031-6989(88)90005-7
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregationInflammation Research, 1986
- Epidemiological characteristics of platelet aggregability.BMJ, 1985
- Comparative Effects of Urapidil, Prazosin, and Clonidine on Ligand Binding to Central Nervous System Receptors, Arterial Pressure, and Heart Rate in Experimental AnimalsThe American Journal of Medicine, 1984
- Interaction of the antihypertensive drug urapidil with cardiac β-adrenoceptors in vitroEuropean Journal of Pharmacology, 1984
- INTERACTION OF SELECTIVE α‐ADRENOCEPTOR AGONISTS AND ANTAGONISTS WITH HUMAN AND RABBIT BLOOD PLATELETSBritish Journal of Pharmacology, 1980
- Investigations on the mode of action of a new antihypertensive drug, urapidil, in the isolated rat vas deferensEuropean Journal of Pharmacology, 1979
- Studies on the Inhibition of Adrenaline-Induced Aggregation of Blood PlateletsPharmacology, 1979
- Characterization of the Human Platelet α-Adrenergic ReceptorJournal of Clinical Investigation, 1978
- Studies on the Effect of Adrenergic Blocking Drugs on Catecholamine‐Induced Platelet Aggregation and Uptake of Noradrenaline and 5‐HydroxytryptamineActa Physiologica Scandinavica, 1969
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962